12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
Several healthcare stocks experienced significant price movements in Tuesday's pre-market session. Notable gainers include GlycoMimetics, Shuttle Pharmaceuticals, and Lixte Biotechnology, while TransMedics Group and Cardio Diagnostics Holdings were among the biggest losers.
October 29, 2024 | 12:08 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
GlycoMimetics stock surged 147.9% in pre-market trading, significantly increasing its market value.
The substantial increase in GlycoMimetics' stock price suggests strong investor interest or positive news, likely leading to a short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Lixte Biotechnology's stock rose by 55.73% in pre-market trading.
The sharp increase in Lixte Biotechnology's stock price suggests positive developments or investor interest, likely leading to a short-term price increase.
CONFIDENCE 85
IMPORTANCE 65
RELEVANCE 75
POSITIVE IMPACT
Shuttle Pharmaceuticals saw a 56.39% increase in its stock price during pre-market trading.
The significant rise in Shuttle Pharmaceuticals' stock price indicates positive sentiment or news, likely leading to a short-term price increase.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Cardio Diagnostics Holdings' stock decreased by 19.18% in pre-market trading.
The significant drop in Cardio Diagnostics Holdings' stock price indicates negative sentiment or news, likely leading to a short-term price decrease.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
TransMedics Group's stock fell 23.6% in pre-market trading following Q3 earnings release.
The decline in TransMedics Group's stock price is likely due to the market's reaction to its Q3 earnings, suggesting a short-term negative impact.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 85